Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
Investors Business Daily
Thu, 03/23/23 - 09:58 am
Tags:
Ionis Pharmaceuticals
,
Biogen
,
ALS
,
FDA
,
tofersen
FDA advisers support conditional clearance of Biogen’s ALS drug
BioPharma Dive
Wed, 03/22/23 - 09:23 pm
Tags:
Biogen
,
ALS
,
FDA
,
tofersen
Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm
BioSpace
Mon, 03/20/23 - 11:40 am
Tags:
ALS
,
Biogen
,
Ionis Pharmaceuticals
,
FDA
,
tofersen
,
clinical trials
Novartis, Biogen Scrap Gene Regulation Partnerships with Sangamo
BioSpace
Mon, 03/20/23 - 09:51 am
Tags:
Sangamo Therapeutics
,
Novartis
,
Biogen
,
neurology
,
gene regulation therapies
Alzheimer's Association campaigns for broader Leqembi coverage: report
Fierce Pharma
Fri, 03/17/23 - 11:43 am
Tags:
CMS
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Biogen's head of neurodegeneration leaves
Fierce Biotech
Fri, 03/17/23 - 10:03 am
Tags:
Biogen
,
women executives
,
Aduhelm
,
Alzheimer's disease
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Seeking Alpha
Thu, 03/16/23 - 09:44 am
Tags:
Biogen
,
EMA
,
Europe
,
MS
,
multiple sclerosis
,
Tecfidera
,
generics
VA to cover Eisai's new Alzheimer's drug after declining to cover Aduhelm
Endpoints
Mon, 03/13/23 - 04:44 pm
Tags:
VHA
,
Eisai
,
Biogen
,
Leqembi
,
Aduhelm
,
Alzheimer's disease
Eisai projects $7B in sales by 2030 for new Alzheimer's drug
Endpoints
Sun, 03/12/23 - 09:40 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
Biogen names Stelios Papadopoulos' successor
Fierce Biotech
Fri, 03/10/23 - 09:45 am
Tags:
Biogen
,
Stelios Papadopoulos
,
Caroline Dorsa
FDA says no adcomm planned for Biogen, Sage's depression drug
Seeking Alpha
Wed, 03/8/23 - 09:47 pm
Tags:
Biogen
,
SAGE Therapeutics
,
FDA
,
zuranolone
,
major depressive disorder
,
postpartum depression
FDA sets July decision date for full approval of Leqembi
BioSpace
Mon, 03/6/23 - 12:11 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
,
FDA
,
lecanemab
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Clinical Trials Arena
Wed, 03/1/23 - 10:05 am
Tags:
Alzheimer's disease
,
Biogen
,
Eisai
,
Lundbeck
,
Otsuka
,
Avanir Pharmaceuticals
,
Axesome
,
Aduhelm
,
Leqembi
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
Tags:
FDA
,
Acadia Pharmaceuticals
,
Apellis Pharmaceuticals
,
AstraZeneca
,
Biogen
,
Biomarin
,
Cidara Therapeutics
,
Emergent BioSolutions
,
GSK
,
Incyte
,
Ionis Pharmaceuticals
,
Melinta Therapeutics
,
Mundipharma
,
Novartis
,
Pfizer
,
Pharming
,
Regeneron
,
Roche
,
vaccines
,
RSV
,
ALS
,
COVID-19
Billy Dunn, FDA’s top neuroscience official to depart agency
RAPS.org
Mon, 02/27/23 - 07:12 pm
Tags:
Billy Dunn
,
FDA
,
Neurosciences
,
Biogen
,
Aduhelm
Medicare maintains limits on Eisai’s new Alzheimer’s drug
BioPharma Dive
Thu, 02/23/23 - 04:27 pm
Tags:
Medicare
,
CMS
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Endpoints
Wed, 02/15/23 - 06:30 pm
Tags:
Biogen
,
InnoCare Pharma
,
orelabrutinib
,
earnings
Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi
Fierce Pharma
Wed, 02/15/23 - 06:26 pm
Tags:
Biogen
,
Chris Viehbacher
,
Stelios Papadopoulos
,
Pharma CEOs
,
Alzheimer's disease
,
Leqembi
FDA adds warning of 'larger areas of bleeding' in brain to Biogen's Aduhelm label
Endpoints
Tue, 02/14/23 - 11:01 am
Tags:
Biogen
,
Aduhelm
,
FDA
,
Alzheimer's disease
Biogen, Sage Get FDA Priority Review of Zuranolone
Marketwatch
Mon, 02/6/23 - 10:47 am
Tags:
Biogen
,
SAGE Therapeutics
,
FDA
,
zuranolone
,
priority review
,
postpartum depression
,
major depressive disorder
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.